Magnus Financial Group LLC Seagen Inc. Transaction History

Magnus Financial Group LLC

  • $838 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023
BUY
$191.51 - $216.16 $192,084 - $216,808
1,003 New
1,003 $212,000
Q1 2023

May 10, 2023
BUY
$127.59 - $203.08 $127,972 - $203,689
1,003 New
1,003 $203,000
Q2 2022

Aug 11, 2022
BUY
$108.81 - $179.33 $152,116 - $250,703
1,398 New
1,398 $247,000

Others Institutions Holding SGEN

# of Institutions
40
Shares Held
1.26M
Call Options Held
23K
Put Options Held
55.2K
View Full List

About Seagen Inc.

SGEN Quotes by TradingView
  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Magnus Financial Group LLC Portfolio

Follow Magnus Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnus Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnus Financial Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email